Pfg Investments, LLC Aldeyra Therapeutics, Inc. Transaction History
Pfg Investments, LLC
- $1.55 Trillion
- Q3 2024
A detailed history of Pfg Investments, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 386,447 shares of ALDX stock, worth $1.82 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
386,447
Previous 396,247
2.47%
Holding current value
$1.82 Million
Previous $1.31 Billion
58.81%
% of portfolio
0.13%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding ALDX
# of Institutions
117Shares Held
36.4MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$43.6 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$25.7 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$17.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$17 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$8.84 Million0.24% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $274M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...